𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Triple-negative breast cancer

✍ Scribed by Rupert Bartsch; Reinhard Ziebermayr; Christoph C. Zielinski; Guenther G. Steger

Publisher
Springer Vienna
Year
2010
Tongue
German
Weight
165 KB
Volume
160
Category
Article
ISSN
0043-5341

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characteristics of triple-negative breas
Characteristics of triple-negative breast cancer
✍ Tim C. de Ruijter; JΓΌrgen Veeck; Joep P. J. de Hoon; Manon van Engeland; Viviann πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 254 KB

## Background Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low five-year survival and high recurrence rates after adjuvant therapy. Overall, TNBC share striking similarities with basal-like brea

Prognostic markers in triple-negative br
Prognostic markers in triple-negative breast cancer
✍ Emad A. Rakha; Maysa E. El-Sayed; Andrew R. Green; Andrew H. S. Lee; John F. Rob πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB
How basal are triple-negative breast can
How basal are triple-negative breast cancers?
✍ FranΓ§ois Bertucci; Pascal Finetti; Nathalie Cervera; Benjamin Esterni; Fabienne πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 99 KB

## Abstract The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression pattern of an intrinsic ∼500‐gene set. It is the most homogeneous subtype in transcriptional terms, and one of the most aggressive in prognostic terms. Clinical trials testing new systemic therapeutic st

Adjuvant therapy of triple negative brea
Adjuvant therapy of triple negative breast cancer
✍ Edith A. Perez; Alvaro Moreno-Aspitia; E. Aubrey Thompson; Cathy A. Andorfer πŸ“‚ Article πŸ“… 2010 πŸ› Springer US 🌐 English βš– 252 KB